An Open-Label, Randomized Crossover Study to investigate the feasibility and applicability of the WatchBP O3 family from Microlife

Withdrawn

• Conditions: high blood pressure; hypertension; 10057166

• Registration Number: NL-OMON33032
• Lead Sponsor: Microlife Corporation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 71

Inclusion Criteria

All patients referred to a hypertensive clinic for primary hypertension. (This means that subjects can also be normotensive after extended diagnosis).

Exclusion Criteria

Patients with uncontrolled primary or secondary causes of hypertension.
Patients with unstable angina, myocardial infarction, transient ischemic attack or stroke within the past 3 months.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Blood pressure measurement values and feasibility as determined by<br /><br>questionnaires filled out by both physicians and subjects.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable.</p><br>